Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
ZBH logo

Zimmer Biomet's Q3 Sales Surge 9.7% Boosted by Paragon Acquisition

ZBH10-QFiling Date: 11/6/2025
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet's Q3 2025 10-Q shows 9.7% net sales growth to $2B, driven by Paragon 28 acquisition and organic demand in orthopedics. Earnings dipped due to taxes and costs, but liquidity strengthened with $1.3B cash. Strategic buys enhance robotics and extremities; restructuring targets savings amid stable risks.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration11:13
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001193125-25-266884

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in